Sbrt±sTad for Unfavorable iNtermediate rIsk/High Risk Prostate caNcer

PHASE2RecruitingINTERVENTIONAL

Enrollment

146

Participants

Timeline

Start Date

February 2, 2021

Primary Completion Date

February 2, 2024

Study Completion Date

February 2, 2027

Conditions

Prostate Cancer

Interventions

DRUG

Decapeptyl

STAD androgen deprivation

Trial Locations (3)

RECRUITING

Ifo Regina elena, Rome

RECRUITING

ifo Regina Elena, Rome

RECRUITING

Regina Elena National Cancer Institute, Rome

All Listed Sponsors

lead

Regina Elena Cancer Institute

OTHER